Prevention of chemotherapy induced cardiotoxicity through lifestyle and pharmacologic interventions
Mitigation of adverse cardiovascular adaptations that occur with long-duration spaceflight
Evaluation of the cardiovascular responses in clinical populations throughout disease progression and following lifestyle and pharmacologic interventions